First Indigenous COVID Drug Vincov-19 Completes Trial, Says CSIR
With the completion of clinical trials that demonstrated excellent results, the primary indigenous drug to treat COVID-19 named Vincov-19 is anticipated to be made available to the general public soon. CSIR-Centre for Cellular & biological science (CCMB), VINS Bioproducts and the University of Hyderabad (UoH) has collaborated to make the drug, Vincov-19. To create this drug, the foremost step taken was the SARS-CoV-2 virus was inactivated and injected into horses. Then the anti-bodies that are generated through the bodily fluid are synthesized to purify and produce a drug. This drug is later on injected into humans to neutralise the COVID virus. The CCMB is an Indian fundamental bioscience research institute based in Hyderabad. UNESCO’s Global Molecular and Cell Biology Networ
Read More